This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of Aaron Lackner
Introduction
Aaron Lackner is a notable inventor based in Berkeley, California. He has made significant contributions to the field of pharmacology, particularly through his work on platelet-activating factor receptor antagonists. His innovative approach has the potential to impact the treatment of various disorders.
Latest Patents
Aaron Lackner holds a patent for Cyclohexyl sulfonamide compounds, which serve as platelet-activating factor (PAF) receptor antagonists. These compounds may be beneficial in treating atherosclerosis and other PAF-mediated disorders, including inflammatory, cardiovascular, and immune disorders. This patent highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Lackner is associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His role at Merck has allowed him to collaborate with other talented professionals in the field. His work is characterized by a focus on innovative solutions to complex medical challenges.
Collaborations
Throughout his career, Aaron Lackner has worked alongside esteemed colleagues such as Anthony K. Ogawa and Feroze Ujjainwalla. These collaborations have fostered a dynamic environment for research and development, leading to advancements in therapeutic options for patients.
Conclusion
Aaron Lackner's contributions to the field of pharmacology through his innovative patents and collaborations exemplify the impact of dedicated
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile